Cite

HARVARD Citation

    Weymann, D. et al. (2017). The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers. Molecular genetics & genomic medicine. 5 (3), pp. 251-260. [Online]. 
  
Back to record